News for Checkpoint Therapeutics, Inc. (CKPT)

Officially completing its acquisition of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT), Sun Pharmaceutical Industries Ltd. has expanded its immuno-oncology footprint.

PR NewswireMUMBAI, India and PRINCETON, N.J., May 30, 2025 MUMBAI, India and PRINCETON, N.J., May 30, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Li

Fortress will receive ~$28 million shortly after closing and is eligible for an additional contingent value right (CVR) of up to $4.8 million, plus a 2.5% roya

Emrosiâ„¢ commercial launch initiated for the treatment of inflammatory lesions of rosacea in adults Fortress subsidiary Checkpoint Therapeutics to be acquired

UNLOXCYTâ„¢ (cosibelimab-ipdl) approved by U.S. FDA in December 2024 as first and only anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma

FDA approves Checkpoint's UNLOXCYTâ„¢ (cosibelimab-ipdl), a first-of-its-kind PD-L1 treatment for advanced cSCC. Checkpoint Therapeutics (CKPT) enters i

NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations

PR NewswireNEW YORK, April 22, 2025 NEW YORK, April 22, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations

Cash Position: Increased to $6.6 million as of December 31, 2024, from $4.9 million at the end of 2023, with an additional $38.1 million received post-year-end

**media[579425]**

Explore Checkpoint Therapeutics' FY earnings with a GAAP EPS of -$1.42. Gain insights into performance and financial outlook.

On March 10, 2025, Beryl Capital Management LLC (Trades, Portfolio) executed a significant transaction by acquiring 6,074,216 shares of Checkpoint Therapeutics

On March 10, 2025, GLAZER CAPITAL, LLC (Trades, Portfolio) executed a noteworthy transaction by acquiring 3,087,052 shares of Checkpoint Therapeutics Inc (CKPT)

PR NewswireNEW YORK, March 17, 2025 NEW YORK, March 17, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following

NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations

Sun Pharma, India's largest pharmaceutical company, is set to acquire Checkpoint Therapeutics for $355 million. This strategic acquisition will enhanc

PR NewswireNEW YORK, March 10, 2025 NEW YORK, March 10, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 700 points on Monday. The Dow traded down 1.43% to 42,190.51 while...